ASO Author Reflections: COVID-19 and Hepatocellular Carcinoma: Vulnerable Patient Populations Will Bear the Brunt of Delayed Treatment.

Rasic, Gordana; Sachs, Teviah E

Rasic, Gordana; Sachs, Teviah E.

Rasic G; Department of Surgery, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Sachs TE; Department of Surgery, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. teviah.sachs@bmc.org.

Ann Surg Oncol ; 30(7): 4260-4261, 2023 Jul.

Article in English | MEDLINE | ID: covidwho-2302336

Subject(s)

COVID-19; Carcinoma, Hepatocellular; Liver Neoplasms; Humans; Carcinoma, Hepatocellular/surgery; Liver Neoplasms/surgery; Time-to-Treatment; Prognosis; Hepatectomy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Carcinoma, Hepatocellular / COVID-19 / Liver Neoplasms Type of study: Prognostic study Limits: Humans Language: English Journal: Ann Surg Oncol Journal subject: Neoplasms Year: 2023 Document Type: Article Affiliation country: S10434-023-13506-3

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google